clofibrate
An aryloxyisobutyric acid derivate with antihyperlipidemic activity. Although the exact mechanism of action has not been fully characterized, clofibrate may enhance the conversion of very-low-density lipoprotein (VLDL) to low-density lipoprotein (LDL), decreasing the production of hepatic VLDL, inhibiting cholesterol production, and increasing fecal excretion of neutral sterols.
US brand name: | Atromid-S |
---|---|
Abbreviation: | CFB |
Chemical structure: | 2-(4-chlorophenoxy)-2-methylpropanoic acid ethyl ester ethyl 2-(4-chlorophenoxy)-2-methylpropanoate ethyl p-chlorophenoxyisobyturate |
NSC code: | 79389 |